Board of Directors approved the financial reports for the second quarter of 2022
· Issued by Tci Gene Inc.
Close
Today's Information
Provided by: TCI GENE INC
SEQ_NO
1
Date of announcement
2022/07/20
Time of announcement
19:44:27
Subject
Board of Directors approved the financial reports
for the second quarter of 2022
Date of events
2022/07/20
To which item it meets
paragraph 43
Statement
1.Date of the financial reports submitted to the board of directors
or approved by the board of directors:2022/07/20
2.Date of the financial reports approved by the audit committee:2022/07/20
3.Start and end dates of financial reports of the reporting period
(XXXX/XX/XX~XXXX/XX/XX):2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):248748
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):143720
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):82988
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):80809
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):67565
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):67266
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):3.02
11.Total assets end of the period (thousand NTD):1195639
12.Total liabilities end of the period (thousand NTD):204396
13.Equity attributable to owners of parent end of the period (thousand NTD):
980199
14.Any other matters that need to be specified:none
